Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2012 Filed May 7, 2012 20:45 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionStock Option · Derivative | 137,930 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-12-016055 · form4.xml · derivative · entry 6 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,043 Underlying: Common Stock · 137,930 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| May 03, 2012 Filed May 7, 2012 20:45 UTC |
SGARRO DOUGLAS AEVP and CLO
|
SaleCommon Stock | 137,930 | $46.19 | $6,370,407.39 |
DisclosureSEC source: 0001127602-12-016055 · form4.xml · nonDerivative · entry 2 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214.1895 F1 · kind: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price with this trading day. Multiple sales were executed, with sales price ranging between $46.17 and $46.21 per share. Read SEC document |
| May 03, 2012 Filed May 7, 2012 20:45 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionCommon Stock | 137,930 | $41.17 | $5,678,578.10 |
DisclosureSEC source: 0001127602-12-016055 · form4.xml · nonDerivative · entry 1 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,144.1895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
SaleCommon Stock | 4,608 | $44.65 | $205,747.20 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 8 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214.1895 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F6 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.64 and $44.66 per share. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantStock Option · Derivative | 66,548 | $45.07 Strike: $45.07 | $2,999,318.36 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · derivative · entry 7 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,548 Underlying: Common Stock · 66,548 shares Expires 2019-04-02 F6 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 48,178 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · derivative · entry 6 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,178 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 2,549 | $45.07 | $114,883.43 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,920.1987 F4 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock (restricted) | 16,641 | $45.07 | $750,009.87 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,573 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 48,178 | $44.96 | $2,166,116.60 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,469.1987 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · shares: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.21 and $45.19 per share. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 19:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 48,178 | $28.10 | $1,353,801.80 |
DisclosureSEC source: 0001127602-12-013290 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,647.1987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:03 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Option · Derivative | 332,736 | $45.07 Strike: $45.07 | $14,996,411.52 |
DisclosureSEC source: 0001127602-12-013293 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,736 Underlying: Common Stock · 332,736 shares Expires 2019-04-02 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:03 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock (restricted) | 83,204 | $45.07 | $3,750,004.28 |
DisclosureSEC source: 0001127602-12-013293 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:06 UTC |
Denton David MEVP, CFO
|
GrantStock Option · Derivative | 110,912 | $45.07 Strike: $45.07 | $4,998,803.84 |
DisclosureSEC source: 0001127602-12-013295 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,912 Underlying: Common Stock · 110,912 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:06 UTC |
Denton David MEVP, CFO
|
Tax withholdingCommon Stock | 800 | $45.07 | $36,056.00 |
DisclosureSEC source: 0001127602-12-013295 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,046.8264 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:06 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock (restricted) | 27,735 | $45.07 | $1,250,016.45 |
DisclosureSEC source: 0001127602-12-013295 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:09 UTC |
Roberts Jonathan CEVP & COO, Caremark
|
GrantStock Option · Derivative | 77,639 | $45.07 Strike: $45.07 | $3,499,189.73 |
DisclosureSEC source: 0001127602-12-013297 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,639 Underlying: Common Stock · 77,639 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:09 UTC |
Roberts Jonathan CEVP & COO, Caremark
|
Tax withholdingCommon Stock | 1,794 | $45.07 | $80,855.58 |
DisclosureSEC source: 0001127602-12-013297 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,819.2866 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:09 UTC |
Roberts Jonathan CEVP & COO, Caremark
|
GrantCommon Stock (restricted) | 19,415 | $45.07 | $875,034.05 |
DisclosureSEC source: 0001127602-12-013297 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & COO, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,228 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:15 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
GrantStock Option · Derivative | 66,548 | $45.07 Strike: $45.07 | $2,999,318.36 |
DisclosureSEC source: 0001127602-12-013298 · form4.xml · derivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,548 Underlying: Common Stock · 66,548 shares Expires 2019-04-02 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:15 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
GrantCommon Stock (restricted) | 16,641 | $45.07 | $750,009.87 |
DisclosureSEC source: 0001127602-12-013298 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,487 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:18 UTC |
Foulkes HelenaExecutive Vice President
|
GrantStock Option · Derivative | 39,929 | $45.07 Strike: $45.07 | $1,799,600.03 |
DisclosureSEC source: 0001127602-12-013299 · form4.xml · derivative · entry 6 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,929 Underlying: Common Stock · 39,929 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:18 UTC |
Foulkes HelenaExecutive Vice President
|
Tax withholdingCommon Stock | 2,551 | $45.07 | $114,973.57 |
DisclosureSEC source: 0001127602-12-013299 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,290.077 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:18 UTC |
Foulkes HelenaExecutive Vice President
|
GrantCommon Stock (restricted) | 9,985 | $45.07 | $450,023.95 |
DisclosureSEC source: 0001127602-12-013299 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,358 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:20 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantStock Option · Derivative | 35,492 | $45.07 Strike: $45.07 | $1,599,624.44 |
DisclosureSEC source: 0001127602-12-013300 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,492 Underlying: Common Stock · 35,492 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:20 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 2,153 | $45.07 | $97,035.71 |
DisclosureSEC source: 0001127602-12-013300 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,786 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:20 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock (restricted) | 8,876 | $45.07 | $400,041.32 |
DisclosureSEC source: 0001127602-12-013300 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,419 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:29 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantStock Option · Derivative | 31,056 | $45.07 Strike: $45.07 | $1,399,693.92 |
DisclosureSEC source: 0001127602-12-013303 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,056 Underlying: Common Stock · 31,056 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:29 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Tax withholdingCommon Stock | 2,578 | $45.07 | $116,190.46 |
DisclosureSEC source: 0001127602-12-013303 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,085 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:29 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
GrantCommon Stock (restricted) | 7,766 | $45.07 | $350,013.62 |
DisclosureSEC source: 0001127602-12-013303 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,968.0004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:47 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantStock Option · Derivative | 26,619 | $45.07 Strike: $45.07 | $1,199,718.33 |
DisclosureSEC source: 0001127602-12-013316 · form4.xml · derivative · entry 4 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,619 Underlying: Common Stock · 26,619 shares Expires 2019-04-02 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:47 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
GrantCommon Stock (restricted) | 6,657 | $45.07 | $300,030.99 |
DisclosureSEC source: 0001127602-12-013316 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,304 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:51 UTC |
Lofberg Per GHEVP and President, Caremark
|
GrantStock Option · Derivative | 347,343 | $45.07 Strike: $45.07 | $15,654,749.01 |
DisclosureSEC source: 0001127602-12-013322 · form4.xml · derivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,343 Underlying: Common Stock · 347,343 shares Expires 2019-12-31 F1 · derivative.exercise_date: Option becomes exercisable on December 31, 2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:55 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 19,965 | $45.07 Strike: $45.07 | $899,822.55 |
DisclosureSEC source: 0001127602-12-013323 · form4.xml · derivative · entry 4 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965 Underlying: Common Stock · 19,965 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:55 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 247 | $45.07 | $11,132.29 |
DisclosureSEC source: 0001127602-12-013323 · form4.xml · nonDerivative · entry 2 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,822.9237 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:55 UTC |
Daniels LairdSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 4,993 | $45.07 | $225,034.51 |
DisclosureSEC source: 0001127602-12-013323 · form4.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,267 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse on 4/2/2016. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionStock Option · Derivative | 64,237 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · derivative · entry 14 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,237 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionStock Option · Derivative | 23,445 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · derivative · entry 13 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,336 Underlying: Common Stock · 23,445 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionStock Option · Derivative | 44,622 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · derivative · entry 12 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,622 Underlying: Common Stock · 44,622 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
SaleCommon Stock | 64,237 | $44.96 | $2,888,095.52 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 7 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,822.1895 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F5 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.21 and $45.18 per share. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
SaleCommon Stock | 23,445 | $44.96 | $1,054,087.20 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 6 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,059.1895 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.21 and $45.18 per share. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
SaleCommon Stock | 44,622 | $44.96 | $2,006,205.12 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 5 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,504.1895 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.21 and $45.18 per share. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionCommon Stock | 64,237 | $28.10 | $1,805,059.70 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 4 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,126.1895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionCommon Stock | 23,445 | $34.96 | $819,637.20 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 3 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,288.1895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Tax withholdingCommon Stock | 3,399 | $45.07 | $153,192.93 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 2 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,889.1895 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:59 UTC |
SGARRO DOUGLAS AEVP and CLO
|
Exercise / conversionCommon Stock | 44,622 | $36.23 | $1,616,655.06 |
DisclosureSEC source: 0001127602-12-013324 · form4.xml · nonDerivative · entry 1 SGARRO DOUGLAS A · CIK 0001194417 · EVP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,843.1895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2012 Filed May 4, 2012 18:47 UTC Amendment |
Foulkes HelenaExecutive Vice President
|
Tax withholdingCommon Stock | 2,551 | $45.07 | $114,973.57 |
DisclosureSEC source: 0001127602-12-015915 · form4a.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,512.077 F1 · balance_after: The purpose of this Amended Form 4A is to correct the total share amount which was reported incorrectly on the original Form 4 due to a computer error. Read SEC document |
| April 02, 2012 Filed Jun 12, 2012 19:54 UTC Amendment |
Daniels LairdSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 4,993 | $45.07 | $225,034.51 |
DisclosureSEC source: 0001127602-12-019906 · form4a.xml · nonDerivative · entry 1 Daniels Laird · CIK 0001479828 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,267 F1 · shares: The purpose of this Form 4/A is to correct the vesting schedule of the reporting person's restricted stock award, which was initially incorrectly reported due to a clerical error. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 20:11 UTC |
MCGUIGAN STUART MSVP and CIO
|
Exercise / conversionStock Option · Derivative | 17,848 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-12-011394 · form4.xml · derivative · entry 6 MCGUIGAN STUART M · CIK 0001335234 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,698 Underlying: Common Stock · 17,848 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 20:11 UTC |
MCGUIGAN STUART MSVP and CIO
|
SaleCommon Stock | 17,848 | $45.22 | $807,086.56 |
DisclosureSEC source: 0001127602-12-011394 · form4.xml · nonDerivative · entry 2 MCGUIGAN STUART M · CIK 0001335234 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,966.6882 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.21 and $45.24 per share. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 20:11 UTC |
MCGUIGAN STUART MSVP and CIO
|
Exercise / conversionCommon Stock | 17,848 | $36.23 | $646,633.04 |
DisclosureSEC source: 0001127602-12-011394 · form4.xml · nonDerivative · entry 1 MCGUIGAN STUART M · CIK 0001335234 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,814.6882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.